These results are consistent with mechanistic data showing that miR-222 promotes leukemic proliferation via WNT/β-catenin activation [21] and that miR-155 drives NF-κB/STAT5-mediated clonal expansion in AML [10]. This evidence concerns the gene NFKB1 and acute myeloid leukemia.